Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pfizer To Pay $150 Million Upfront To Fosun Pharma In New China Move
Shanghai Fosun Pharmaceutical is one of China's largest pharmaceutical companies. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) SOPA Images/LightRocket via Getty Images In its latest agreement with a China partner…
Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S
Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S Pharma Equity Group A/S ('PEG') today announces that the company has signed a Letter of Intent regarding the…
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
HERZLIYA, Israel and CALGARY, AB, Dec. 10, 2025 /CNW/ -- Innocan Pharma Corporation ('Innocan' or the 'Company') (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed…
This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence
Healthcare stocks have lagged the broader market for the past three years, weighed down by post-COVID earnings volatility, policy uncertainties around drug pricing, and a surge in tech-driven gains from the AI boom. The sector's relative earnings…
BridgeBio Pharma (NASDAQ:BBIO) CAO Sells $148,520.00 in Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CAO Maricel Apuli sold 2,000 shares of BridgeBio Pharma stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $74.26, for a total value of $148,520.00.
Menora Mivtachim Holdings LTD. Reduces Holdings in Urogen Pharma $URGN
Menora Mivtachim Holdings LTD. reduced its position in Urogen Pharma (NASDAQ:URGN - Free Report) by 50.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,152,531 shares of the company's stock after…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Here's What Happened
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report)'s share price gapped down prior to trading on Wednesday. The stock had previously closed at $31.31, but opened at $29.80. Ascentage Pharma Group International…
Stempoint Capital LP Reduces Stock Holdings in BridgeBio Pharma, Inc. $BBIO
Stempoint Capital LP cut its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 73.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,630…
Stempoint Capital LP Boosts Stake in NewAmsterdam Pharma Company N.V. $NAMS
Stempoint Capital LP lifted its position in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 46.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm…
Royalty Pharma (NASDAQ:RPRX) EVP Sells $913,526.10 in Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 23,334 shares of Royalty Pharma stock in a transaction on Friday, December 5th. The stock was sold at an average price of $39.15, for a total value of $913,526.10. Following…
California Public Employees Retirement System Sells 268,263 Shares of Royalty Pharma PLC $RPRX
California Public Employees Retirement System lessened its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 15.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission…
Drug rebate rate cut by over a third after zero-tariff deal with US
Sign up for our email featuring expert insight and funding opportunities for entrepreneurs and SMEs I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. Rebates paid by drugs firms to the NHS…
The Fed meeting, pressure on Oracle, Target's fashion-forward renovation and more in Morning Squawk
Fed funds futures are pricing in a nearly 90% chance of a quarter percentage point reduction to the central bank's key interest rate. Eli Lilly said it will spend $6 billion building an Alabama manufacturing plant that will support production of…
Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
Collaboration leverages OBT's proprietary OGAP-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology targets The agreement - OBT's second high-profile pharma collaboration this year - reflects the strong…
Health Ministry discusses with Saudi investor, and others, establishment of a pharmaceutical factory in Libya
The Tripoli based Libyan Ministry of Health reported (yesterday / Tuesday 9 December) that the Undersecretary and Acting Minister of Health, Mohammed Al-Ghouj, and representatives from the Ministry of Economy, held a virtual meeting with several…
Receive a Daily briefing on Pharma Industry News
Get Started